Author

Di Yang

Army Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Organism:mouse· 1

Frequent Co-Authors

Ananthan SadagopaniD· 1 shared Benjamin Jacob DrapkiniD· 1 shared Bingchen LiiD· 1 shared Cary N. WeissiD· 1 shared Chao Han· 1 shared Christy Biji· 1 shared Chun Lan· 1 shared Dharma R. Thapa· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ananthan SadagopanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

LARP4 is a B cell-specific metabolic checkpoint for plasma cell differentiation and a therapeutic target in systemic lupus erythematosus

Huanzi Dai, Mingyang Zhang, Chun Lan, Fei Xiao, Junhui Deng, hui Dong, Chao Han, Jian Zhou, Shufeng Wang, Jingxue Wang, Yaxing Hao, Yiwei Zhang, Zhaohui Zhang, Yi Sun, Jie Luo, , Yi Tian

bioRxiv · Jul 15, 2026 · PreprintImmunology

Cancer target discovery enabled by transcriptome-based virtual CRISPR screening

Ananthan Sadagopan, Bingchen Li, Jiao Li, Yantong Cui, Riva Deodhar, Di Yang, Yifan Wu, Prathyusha Konda, Christy Biji, Dharma R. Thapa, Meha Thakur, Cary N. Weiss, Toni K. Choueiri, Jaimie H. Cheah, John G. Doench, , Srinivas Raghavan Viswanathan

This study uses machine learning to infer gene dependencies from tumor transcriptomes, identifying cancer vulnerabilities in rare cancers without experimental screening.

bioRxiv · Oct 24, 2024 · PreprintCancer Biology